🇺🇸 FDA
Pipeline program

Florbetapir F 18 (18F-AV-45)

20110506

Approved small_molecule active

Quick answer

Florbetapir F 18 (18F-AV-45) for Postoperative Cognitive Dysfunction is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Postoperative Cognitive Dysfunction
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials